cagrilintide tirzepatide combination study Three new phase 3 REIMAGINE studies provide some of the strongest evidence yet for CagriSema® (cagrilintide + semaglutide) in type 2 diabetes. 🔹 REIMAGINE 1 Studied people with early type 2 diabetes Cagrilintide | RETA UK —

Hexanoyl-Tyr-Ile-Ahx-NH2 Dihexa, an oligopeptide drug, is an orally active and blood-brain barrier-permeable angiotensin IV analog

Many supplements are available in high doses, which can make it easy to consume more than your body actually needs

BPC-157 is legal in Thailand when prescribed by a licensed Thai physician

Thailand attracts so much demand because peptide therapy is more accessible here than in most Western countries, the cost is significantly lower and licensed doctors can prescribe clinical-grade peptides legally

Faecalibacterium prausnitzii increased 41% over placebo Anaerostipes increased 67% over placebo Both bacteria are butyrate producers and their benefits are associated with butyrate production (healthy microbiome, immunity, healthy inflammatory response, etc.) Tributyrin (as CoreBiome) Is the #1 selling SCFA on the market Has clinically substantiated bioavailability in the colon In a 48-hour study using a gastrointestinal model [and that was repeated in a four-week study], CoreBiome limited IL6, TNF-alpha and measurements of epithelial function through TEER (transepithelial electrical resistance), suggesting that it may support gut barrier function Is the ONLY SCFA with marketable claims Synergy with Larazotide, Guttides (BPC-157 + KPV): Critical component of GI protocols including Guttides (BPC-157 + KPV), Larazotide and low dose pentosan polysulfate